Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Alimentary Pharmacology & Therapeutics|November 4, 2020
The significance of histological activity measurements in immune checkpoint inhibitor colitisRish K Pai, Reetesh K Pai, Ian Brown, et al.JAMA Oncology|May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract CancerRichard D Kim, Vincent Chung, Olatunji B Alese, et al.Biochemical Pharmacology|August 23, 2015
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expressionHwan-Jin Hwang, Tae Woo Jung, Baek-Hui Kim, et al.Journal of Clinical Pathology|September 22, 2023
Unravelling interobserver variability in gastrointestinal glandular neoplasia: a contemporary study of US and Korean pathologistsRichard R Pacheco, Hyunki Kim, Won-Tak Choi, et al.Oncotargets and Therapy|August 9, 2018
Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patientsHong Jun Kim, Min Jee Jo, Bo Ram Kim, et al.Clinical and Molecular Hepatology|June 21, 2017
Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive reviewTae Suk Kim, Ji Hoon Kim, Baek Hui Kim, et al.Clinical Endocrinology|October 17, 2012
The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trialKyung Mook Choi, Kyung Ah Han, Hee Jung Ahn, et al.Plos One|August 6, 2021
Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expressionJeong-An Gim, Soo Min Bang, Young-Sun Lee, et al.The Korean Journal of Internal Medicine|July 11, 2022
Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis modelsSeong Hee Kang, Hyung Joon Yim, Ji-Won Hwang, et al.Hepatology International|March 7, 2022
MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseYoung-Sun Lee, Ji Eun Lee, Hyon-Seung Yi, et al.Pageof 9